Trial Profile
The effects of low molecular weight heparin [enoxaparin sodium] and aspirin therapy on recurrent pregnancy loss
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary) ; Aspirin
- Indications Embolism and thrombosis; Pregnancy; Spontaneous abortion
- Focus Therapeutic Use
- Acronyms SPIN
- 31 May 2012 Additional lead trial centres added as reported by United Kingdom Clinical Research Network record.
- 30 Jul 2010 Additional trial centres identified as reported by United Kingdom Clinical Research Network record.
- 30 Jul 2010 New source identified and integrated (United Kingdom Clinical Research Network).